Evidence map›Paper›PMID 33666856›Full record

ReviewCurrent heart failure reports2021

Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction.

Hunter Mwansa, Sabra Lewsey, Sula Mazimba, Khadijah Breathett

Open access · greenAbstract readReview
In one paragraph

Review in Current heart failure reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Patient Perspectives on Delayed Specialty Follow-Up After a Primary Care Visit.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Racial, Ethnic, Socioeconomic, and Geographic Inequities in Access to Mechanical Circulatory Support.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Hunter MwansaSaint Francis Medical Center/University of Illinois College of Medicine, Peoria, IL, USA.
Sabra LewseyDivision of Cardiovascular Medicine, Johns Hopkins University, Baltimore, MD, USA.
Sula MazimbaDivision of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA, USA.
Khadijah BreathettDivision of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, 1501 North Campbell Avenue, PO Box 245046, Tucson, AZ, 85724, USA. kbreathett@shc.arizona.edu.ORCID http://orcid.org/0000-0001-5397-6419
Johns Hopkins University · USSt. Francis Medical Center · USUniversity of Arizona · USUniversity of Virginia Health System · US

Funding

UCSF Research in Implementation Sciences for Equity (RISE)R25HL126146 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRYSTAL WILEY CENE, Alicia Fernandez · 2014 to 2026
$4.6M
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic MinoritiesK01HL142848 · NHLBI · UNIVERSITY OF ARIZONA · PI BREATHETT, KHADIJAH · 2018 to 2021
$858k
NHLBI NIH HHS K01 HL142848NHLBI NIH HHS L30 HL148881NHLBI NIH HHS R25 HL126146
6 · The paper itself

Abstract

purpose of reviewThis review highlights variability in prescribing of nonpharmacologic heart failure with reduced ejection fraction (HFrEF) therapies by race, ethnicity, and gender. The review also explores the evidence underlying these inequalities as well as potential mitigation strategies. RECENT

findingsThere have been major advances in HF therapies that have led to improved overall survival of HF patients. However, racial and ethnic groups of color and women have not received equitable access to these therapies. Patients of color and women are less likely to receive nonpharmacologic therapies for HFrEF than White patients and men. Therapies including exercise rehabilitation, percutaneous transcatheter mitral valve repair, cardiac resynchronization therapy, heart transplant, and ventricular assist devices all have proven efficacy in patients of color and women but remain underprescribed. Outcomes with most nonpharmacologic therapy are similar or better among patients of color and women than White patients and men. System-level changes are urgently needed to achieve equity in access to nonpharmacologic HFrEF therapies by race, ethnicity, and gender.

Indexed as

Cardiac Resynchronization TherapyHeart-Assist DevicesHeart FailureEthnicityFemaleHumansMaleStroke VolumeEthnicityHealth disparitiesHeart failureOutcomesRaceWomen’s health

Identifiers

PMID33666856
PMCPMC7989038
OpenAlexW3135710210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.